U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07012005) titled 'Study of BPN14770 in Participants With Severe Renal Impairment and Healthy Controls' on June 02.
Brief Summary: The purpose of this study is to assess the pharmacokinetics (PK), safety, and tolerability of BPN14770 in participants with severe renal impairment and those with normal renal function.
Study Start Date: June 03
Study Type: INTERVENTIONAL
Condition:
Renal Impairment
Intervention:
DRUG: BPN14770
BPN14770 will be administered per schedule specified in the arm description.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Shionogi
Disclaimer: Curated by HT Syndication....